WBSCR22 and TRMT112 are responsible for mediating m7G methylation in rRNA (47). A recent study demonstrated that WBSCR22 is upregulated in glioma and increases its growth and proliferation via activation of the PI3K/AKT/GSK3β pathways (119). Here, AKT1 is linked to central nervous system cancer.